With the EU and US GMP capabilities from our facility in Oss, BioConnection is proud to assist VarmX to accelerate the GMP manufacturing trajectory and bring VMX-C001 into clinical trials and ultimately to patients who currently have limited options to effective and safe treatments. VMX-C001 Immediately restores blood clotting in the presence of direct factor Xa anticoagulants.
BioConnection is honoured to support VarmX
Let's connect
If you’re exploring fill & finish support for an upcoming or ongoing program, we’d love to learn more about your goals and how we can contribute to your success. Whether you’re evaluating partners for a new project or preparing for your next development milestone, our team is ready to support you with clarity, expertise, and flexibility.
Share a few details about your molecule, timelines, or specific challenges, and we’ll follow up with insights tailored to your needs. By understanding your priorities early, we can determine how our capabilities, capacity, and approach align with your plans. We’re here to help.